Healt


 SUDA welcomes Australian Government’s Initiatives to Foster Medical Marijuana Industry

SUDA welcomes Australian Government’s Initiatives to Foster Medical Marijuana Industry

August 09, 2019 01:24 PM AEST| By Team Kalkine Media

To increase the bioavailability of administered medications, Australian-headquartered SUDA Pharmaceuticals Ltd (ASX: SUD) is reformulating medications into an oral spray. The delivery of medications through the oral mucosa increases the amount of the...

 A Look at 4 ASX-Listed Healthcare Stocks - SHL, COH, NAN and PME

A Look at 4 ASX-Listed Healthcare Stocks - SHL, COH, NAN and PME

August 08, 2019 05:57 PM AEST| By Team Kalkine Media

Introduction of information technology into the healthcare industry has helped medical practitioners to diagnose and detect diseases promptly and accurately. Nowadays, technology has a significant impact in each industry. In the healthcare sector, te...

 Melbourne soon to be home to CSL’s HQ and laboratories; market awaits yearly results

Melbourne soon to be home to CSL’s HQ and laboratories; market awaits yearly results

August 08, 2019 05:37 PM AEST| By Team Kalkine Media

Discoveries in life sciences, be it in the field of agriculture, human health, environment, information technology, food or bioinformatics, has been driving the growth of businesses since the last few decades. In the contemporary and dynamic world, t...

 Healthcare Company, 1st Group Records 41% Revenue Growth in June 2019 Quarter

Healthcare Company, 1st Group Records 41% Revenue Growth in June 2019 Quarter

August 08, 2019 01:15 PM AEST| By Team Kalkine Media

1st Group Limited (ASX: 1ST), a healthcare sector company based in Sydney, Australia, supplies a convenient, straightforward, integrated technology platform to aid online search and appointment reservation services? to the healthcare services industr...

 A Glance at Imugene’s B-Cell Vaccine Developments in 2019

A Glance at Imugene’s B-Cell Vaccine Developments in 2019

August 07, 2019 02:41 PM AEST| By Team Kalkine Media

An Australian-headquartered clinical stage biotechnology company, Imugene Limited (ASX: IMU) seeks to develop different novel immunotherapies to boost the efficacy of cancer treatments. Imugene?s product pipeline covers oncolytic viruses and several...

 SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMist Clinical Study Results

SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMist Clinical Study Results

August 06, 2019 09:55 PM AEST| By Team Kalkine Media

SUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery company that is reformulating medication into an oral spray to improve the bioavailability of administered medications. By delivering the drugs through the oral mucosa, the company h...

 Opportunities In Personalised Medicine Industry On Prescient’s Radar

Opportunities In Personalised Medicine Industry On Prescient’s Radar

August 05, 2019 09:16 PM AEST| By Team Kalkine Media

Clinical stage oncology company, Prescient Therapeutics Limited (ASX: PTX) is engaged in developing personalised medicines to treat a range of challenging cancers. The company is known for having one of the deepest clinical pipelines on ASX, with two...

 Healthcare Stocks In Focus - ANN, SHL, PME

Healthcare Stocks In Focus - ANN, SHL, PME

August 03, 2019 09:00 AM AEST| By Team Kalkine Media

Healthcare is one of the largest sectors in Australia, not only in terms of size but also in contributions towards the country?s economy. As demand for healthcare products and services is increasing across Australia, investments in the discovery of n...

 AFT Pharmaceuticals Reports Robust Annual Results; Strong Sales And Financial Performance

AFT Pharmaceuticals Reports Robust Annual Results; Strong Sales And Financial Performance

August 02, 2019 10:17 PM AEST| By Team Kalkine Media

A growing multinational pharmaceutical company, AFT Pharmaceuticals Limited (ASX: AFP) is engaged in the marketing, distribution and development of an extensive portfolio of pharmaceutical products that covers a broad range of therapeutic categories....

 Regeneus Progressing Well To Commercialise Progenza In Japan By 2023; Undertakes strategic capital raising initiatives

Regeneus Progressing Well To Commercialise Progenza In Japan By 2023; Undertakes strategic capital raising initiatives

August 02, 2019 06:51 PM AEST| By Team Kalkine Media

Australian clinical-stage regenerative medicine company,?Regeneus Ltd (ASX: RGS) recently announced positive results from its preclinical trial of Progenza in the treatment of allodynia, a condition in which pain occurs from non-painful stimulation o...

 Five Pharma Stocks – AVH, MSB, THC, AC8 and CUV

Five Pharma Stocks – AVH, MSB, THC, AC8 and CUV

August 02, 2019 04:17 PM AEST| By Team Kalkine Media

The following pharmaceutical sector companies have recently disclosed their June 2019 quarterly updates. Let us have a brief glance at how these companies faired in the recent three months. AVITA Medical Ltd AVITA Medical Ltd (ASX: AVH), a medicine...

 SUDA’s June Quarterly Report Out On ASX; A Look At Its Business And Technology

SUDA’s June Quarterly Report Out On ASX; A Look At Its Business And Technology

August 01, 2019 09:40 PM AEST| By Team Kalkine Media

On 31 July 2019, SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery firm, has released its June quarterly updates on the ASX. SUDA mentioned that it witnessed several key developments during the quarter including restructuring of board...

 7 Health Care Stocks With Quarterly Update – ZLD, MX1, SVA, CGS, BNO, TLX And OSL

7 Health Care Stocks With Quarterly Update – ZLD, MX1, SVA, CGS, BNO, TLX And OSL

July 31, 2019 09:48 PM AEST| By Team Kalkine Media

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in the process...

 ASX: BOT climbing up the ASX ladder; Progressing Well with its Robust Product Portfolio

ASX: BOT climbing up the ASX ladder; Progressing Well with its Robust Product Portfolio

July 31, 2019 05:09 PM AEST| By Team Kalkine Media

Botanix Pharmaceuticals Limited (ASX: BOT) is an Australian-headquartered company, engaged in the development of next-gen therapeutics that are safe and effective for the treatment of serious skin diseases. It is a clinical stage cannabinoid company...

 Pfizer Signs All-Stock Agreement with Mylan to Create Global Pharma Champion

Pfizer Signs All-Stock Agreement with Mylan to Create Global Pharma Champion

July 31, 2019 01:17 PM AEST| By Team Kalkine Media

In the face of a rapidly shifting pharmaceutical market, to be successful, pharmaceutical companies need to innovate, work more efficiently and boost their product portfolios. Moreover, large pharma and biotech companies often engage in merging their...

 A Look at Australian Pharma Player, Pharmaxis Ltd’s Products and Its Amine Oxidase Platform

A Look at Australian Pharma Player, Pharmaxis Ltd’s Products and Its Amine Oxidase Platform

July 29, 2019 07:18 PM AEST| By Team Kalkine Media

An Australian pharmaceutical research company focussing on fibrotic and inflammatory diseases, Pharmaxis Ltd (ASX: PXS) holds a portfolio of products which are at various stages of development and approval. The product pipeline of the company is cent...

 A quick “Check-up” of four Healthcare stocks - 1ST, OSL , IVQ , PIQ

A quick “Check-up” of four Healthcare stocks - 1ST, OSL , IVQ , PIQ

July 29, 2019 01:09 PM AEST| By Team Kalkine Media

Australia is a powerhouse of biotechnology and pharmaceutical innovation that is being driven by world-class research facilities, leading scientists and a strong yet flexible regulatory regime. Lets us take a look at the following four companies from...

 Imugene Releases Bioshares Presentation and Quarterly Updates; Stock Zooms up

Imugene Releases Bioshares Presentation and Quarterly Updates; Stock Zooms up

July 29, 2019 12:02 PM AEST| By Team Kalkine Media

An emerging leader in cancer immuno-oncology, Imugene Limited (ASX: IMU) is a clinical stage biotechnology company seeking to develop a range of novel immunotherapies to enhance the efficacy of cancer treatments. Imugene has released its Quarterly A...

 Noxopharm secures AU$26 million funding facility to ramp up the development of Veyonda®

Noxopharm secures AU$26 million funding facility to ramp up the development of Veyonda®

July 29, 2019 11:46 AM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) plans to accelerate the development of Veyonda? on the foundation of its encouraging interim results from both its DARRT-1 and LuPIN studies. The most recent ?interim data supports the company?s belief that its immuno-onc...

 Healthcare Stocks In Penny Space - RNO, IDT, SCU

Healthcare Stocks In Penny Space - RNO, IDT, SCU

July 28, 2019 08:30 AM AEST| By Team Kalkine Media

Australia?s pharmaceutical industry is innovative and immensely supports economic prosperity of the nation. The constituent companies not only provide treatments to save lives but also contribute to Australian economy by undertaking business, researc...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.